Effects of exenatide on kidney function, adverse events, and clinical end points of kidney disease in type 2 diabetes.

Tuttle, Katherine R; Heilmann, Cory; Hoogwerf, Byron J; Brown, Carl; Anderson, Pamela W

Tuttle, Katherine R; Heilmann, Cory; Hoogwerf, Byron J; Brown, Carl; Anderson, Pamela W.

Am J Kidney Dis ; 62(2): 396-8, 2013 Aug.

Article in En | MEDLINE | ID: mdl-23684754

Subject(s)

Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/physiopathology; Diabetic Nephropathies/physiopathology; Hypoglycemic Agents/adverse effects; Kidney/drug effects; Peptides/adverse effects; Venoms/adverse effects; Exenatide; Female; Humans; Kidney/physiopathology; Male; Middle Aged; Randomized Controlled Trials as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Venoms / Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Hypoglycemic Agents / Kidney Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Am J Kidney Dis Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google